Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.4810
+0.0010 (0.21%)
Apr 25, 2025, 5:35 PM CET

Celyad Oncology Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
202916117992
Upgrade
Market Cap Growth
82.56%82.56%41.33%-85.61%-13.96%-31.75%
Upgrade
Enterprise Value
172412-17669
Upgrade
Last Close Price
0.480.710.390.513.526.62
Upgrade
PS Ratio
107.14158.59158.40--18459.66
Upgrade
PB Ratio
39.0057.722.562.651.822.98
Upgrade
P/TBV Ratio
40.83278.272.582.9610.00-
Upgrade
EV/Sales Ratio
89.42130.42114.87--13862.06
Upgrade
Debt / Equity Ratio
1.771.770.170.060.060.12
Upgrade
Asset Turnover
0.010.010.01--0
Upgrade
Quick Ratio
1.761.763.341.312.341.53
Upgrade
Current Ratio
2.292.293.791.422.481.67
Upgrade
Return on Equity (ROE)
-170.92%-170.92%-159.08%-170.72%-71.05%-44.91%
Upgrade
Return on Assets (ROA)
-27.94%-27.94%-33.03%-31.92%-23.32%-21.04%
Upgrade
Return on Capital (ROIC)
-83.42%-83.42%-99.63%-62.57%-42.08%-38.76%
Upgrade
Earnings Yield
-29.23%-19.74%-52.29%-358.06%-33.38%-18.64%
Upgrade
FCF Yield
--19.26%-99.65%-246.08%-33.97%-30.14%
Upgrade
Buyback Yield / Dilution
-61.73%-61.73%-13.84%-44.80%-11.92%-11.33%
Upgrade
Updated Sep 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.